.@AstraZeneca has said that it will supply the vaccine to developing countries at cost. @Pfizer, in contrast, has committed to profit maximise for its shareholders from its vaccine.

Ownership matters. Good thing the Pfizer takeover of AZ in 2014 failed: https://t.co/t5jZg0nu77.

— Tom Kibasi (@TomKibasi) November 23, 2020